NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001671

Registered date:01/02/2009

The comparative study of the effects of miglitol and voglibose (alpha-glucosidase inhibitors) on incretins secretion

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedtype-2 diabetes
Date of first enrollment2008/12/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)miglitol 50 mg thrice a day voglibose 0.3 mg thrice a day

Outcome(s)

Primary OutcomeCoparisons of changes in plasma glucose, insulin, GLP-1 and GIP in response to a mixed meal before and after administration of miglitol or voglibose.
Secondary OutcomeHbA1c, body weight, BMI, serum levels of adiponectin, high-sense CRP and MCP-1 at baseline and 3 month aftrer administrations of miglitol or voglibose.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1) type-1 diabetes 2) severe hepatic or renal disease 3) severe heart disease 4) having canceres 5) unstable diabetic retinpathy 6) having a condyion to be worsened by increase in intestinal gas 7) a woman who is nursing or pregnant 8) after gstrectomy 9) a patient who is judged as not appropriate for participation

Related Information

Contact

public contact
Name Takuma Narita
Address Japan
Telephone
E-mail narita@med.akita-u.ac.jp
Affiliation Akita University School of Medicine Department of Endocrinology, Diabetes and Geriatric Medicine
scientific contact
Name Takuma Narita
Address 1-1-1 Hondo, Akita-city, Japan Japan
Telephone
E-mail
Affiliation Akita University School of Medicine Department of Endocrinology, Diabetes and Geriatric Medicine